J 106366
Latest Information Update: 08 Aug 2002
Price :
$50 *
At a glance
- Originator Banyu
- Class Antiasthmatics; Bronchodilators
- Mechanism of Action Muscarinic M3 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Chronic obstructive pulmonary disease
Most Recent Events
- 21 Sep 1998 Preclinical development for Chronic obstructive pulmonary disease in Japan (Unknown route)